Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Liebman

Showing results (171-180 of 216) with videos related to

Pageof 22
Sort By:
Journal of Pharmaceutical Sciences|May 1, 1976
Bumetanide: radioimmunoassay and pharmacokinetic profile in humansW R Dixon, R L Young, A Holazo, et al.
International Journal of Peptide and Protein Research|October 1, 1977
Synthesis, biological activity, and tritiation of L-3, 4-dehydroproline-containing peptidesA M Felix, C T Wang, A A Liebman, et al.
The Journal of Biological Chemistry|July 5, 1989
Factor IX San Dimas. Substitution of glutamine for Arg-4 in the propeptide leads to incomplete gamma-carboxylation and altered phospholipid binding propertiesJ Ware, D L Diuguid, H A Liebman, et al.
Reviews of Infectious Diseases|July 1, 1990
Treatment of AIDS and AIDS-related complex with 2',3'-dideoxyinosine given once dailyT P Cooley, L M Kunches, C A Saunders, et al.
The New England Journal of Medicine|May 10, 1990
Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trialT P Cooley, L M Kunches, C A Saunders, et al.
Journal of Thrombosis and Haemostasis : JTH|October 20, 2010
Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanningC O'Connell, P Razavi, M Ghalichi, et al.
Gynecologic Oncology|December 25, 2012
Predictive model of venous thromboembolism in endometrial cancerKoji Matsuo, Annie A Yessaian, Yvonne G Lin, et al.
Thrombosis Research|May 11, 2016
OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparinC I Piatek, S T Tagawa, D Wei-Tsai, et al.
The New England Journal of Medicine|May 31, 1984
Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinomaH A Liebman, B C Furie, M J Tong, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1992
Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trialsG L Drusano, G J Yuen, G Morse, et al.
Pageof 22

Showing results (171-180 of 216) with videos related to

Sort By:
Pageof 22
Journal of Pharmaceutical Sciences|May 1, 1976
Bumetanide: radioimmunoassay and pharmacokinetic profile in humansW R Dixon, R L Young, A Holazo, et al.
International Journal of Peptide and Protein Research|October 1, 1977
Synthesis, biological activity, and tritiation of L-3, 4-dehydroproline-containing peptidesA M Felix, C T Wang, A A Liebman, et al.
The Journal of Biological Chemistry|July 5, 1989
Factor IX San Dimas. Substitution of glutamine for Arg-4 in the propeptide leads to incomplete gamma-carboxylation and altered phospholipid binding propertiesJ Ware, D L Diuguid, H A Liebman, et al.
Reviews of Infectious Diseases|July 1, 1990
Treatment of AIDS and AIDS-related complex with 2',3'-dideoxyinosine given once dailyT P Cooley, L M Kunches, C A Saunders, et al.
The New England Journal of Medicine|May 10, 1990
Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trialT P Cooley, L M Kunches, C A Saunders, et al.
Journal of Thrombosis and Haemostasis : JTH|October 20, 2010
Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanningC O'Connell, P Razavi, M Ghalichi, et al.
Gynecologic Oncology|December 25, 2012
Predictive model of venous thromboembolism in endometrial cancerKoji Matsuo, Annie A Yessaian, Yvonne G Lin, et al.
Thrombosis Research|May 11, 2016
OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparinC I Piatek, S T Tagawa, D Wei-Tsai, et al.
The New England Journal of Medicine|May 31, 1984
Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinomaH A Liebman, B C Furie, M J Tong, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1992
Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trialsG L Drusano, G J Yuen, G Morse, et al.
Pageof 22